OptimizeRx Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,957.00
6,503.00
7,220.70
7,751.50
12,127.40
21,206.40
Cost of Goods Sold (COGS) incl. D&A
3,281.10
6,135.60
5,744.60
3,646.70
6,499.20
11,837
Gross Income
1,675.90
367.40
1,476.10
4,104.80
5,628.30
9,369.30
SG&A Expense
1,460.30
993.70
2,073.50
5,636.30
7,758.20
8,581.50
EBIT
215.60
626.30
597.40
1,531.50
2,130.00
787.80
Unusual Expense
-
400.00
-
50.00
-
607.70
Pretax Income
215.80
1,025.40
595.10
1,539.20
2,104.00
226.30
Consolidated Net Income
215.80
1,025.40
595.10
1,539.20
2,104.00
226.30
Net Income
215.80
1,025.40
595.10
1,539.20
2,104.00
226.30
Net Income After Extraordinaries
215.80
1,025.40
595.10
1,539.20
2,104.00
226.30
Net Income Available to Common
215.80
1,025.40
595.10
1,539.20
2,104.00
226.30
EPS (Basic)
0.04
0.13
0.06
0.15
0.21
0.02
Basic Shares Outstanding
4,796.00
7,460.80
8,187.50
9,902.60
9,819.80
10,832.20
EPS (Diluted)
0.04
0.13
0.07
0.16
0.21
0.02
Diluted Shares Outstanding
4,904.30
8,002.80
8,187.50
9,902.60
9,819.80
11,863
EBITDA
409.60
362.00
263.50
1,296.20
1,805.40
1,104.30
Non-Operating Interest Income
0.20
0.90
2.30
42.30
25.90
46.20
About OptimizeRx
View Profile
